Literature DB >> 19224981

Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder?

Emily C Somers1, Sara L Thomas, Liam Smeeth, Andrew J Hall.   

Abstract

Limited evidence suggests that autoimmune diseases tend to co-occur, although data are needed to determine whether individuals with an existing autoimmune disorder are at increased risk of a second disorder. The authors conducted a series of population-based cohort studies, utilizing the United Kingdom General Practice Research Database, to assess intraindividual risks of coexistence of rheumatoid arthritis (RA), autoimmune thyroiditis (AIT), multiple sclerosis (MS), and insulin-dependent diabetes mellitus (IDDM) during 1990-1999. Sex-specific age- and calendar-period standardized incidence ratios (SIRs) were calculated for development of a second autoimmune disease among index populations including 22,888 RA, 26,198 AIT, 4,332 MS, and 6,170 IDDM patients compared with the general population. Among those with IDDM, adjusted AIT rates were higher than expected for both males (SIR = 646.0, 95% confidence interval (CI): 466, 873) and females (SIR = 409.6, 95% CI: 343, 485), as were RA rates for females (SIR = 181.6, 95% CI: 136, 238). Coexistence of AIT and RA was also shown for either disease sequence (sex-specific SIRs = 130.4-162.0). However, point estimates suggested an inverse relation between RA and MS, irrespective of diagnostic sequence. This study demonstrates coexistence of RA, AIT, and IDDM at higher than expected rates but reduced comorbidity between RA and MS.

Entities:  

Mesh:

Year:  2009        PMID: 19224981     DOI: 10.1093/aje/kwn408

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  52 in total

1.  The multiple autoimmune syndromes. A clue for the autoimmune tautology.

Authors:  Juan-Manuel Anaya; John Castiblanco; Adriana Rojas-Villarraga; Ricardo Pineda-Tamayo; Roger A Levy; José Gómez-Puerta; Carlos Dias; Ruben D Mantilla; Juan Esteban Gallo; Ricard Cervera; Yehuda Shoenfeld; Mauricio Arcos-Burgos
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 2.  Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Authors:  Ethan Craig; Laura C Cappelli
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

Review 3.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

Review 4.  Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis.

Authors:  Sofie Bliddal; Stina Willemoes Borresen; Ulla Feldt-Rasmussen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

5.  Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients.

Authors:  Clement E Tagoe; Anna Zezon; Saakshi Khattri; Patricia Castellanos
Journal:  Rheumatol Int       Date:  2013-01-05       Impact factor: 2.631

6.  2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism.

Authors:  Wilmar M Wiersinga; Leonidas Duntas; Valentin Fadeyev; Birte Nygaard; Mark P J Vanderpump
Journal:  Eur Thyroid J       Date:  2012-06-13

7.  Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts.

Authors:  Dana L Catalfamo; Nadia L Calderon; Scott W Harden; Heather L Sorenson; Kathleen G Neiva; Shannon M Wallet
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

Review 8.  Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Authors:  Scott J Pilla; Amy Q Quan; Emily L Germain-Lee; David B Hellmann; Nestoras N Mathioudakis
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

Review 9.  Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.

Authors:  Ruth Dobson; Gavin Giovannoni
Journal:  J Neurol       Date:  2013-01-12       Impact factor: 4.849

Review 10.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.